1
|
Gaffney-Stomberg E: The impact of trace
minerals on bone metabolism. Biol Trace Elem Res. 188:26–34.
2019.PubMed/NCBI View Article : Google Scholar
|
2
|
Kini U and Nandeesh B: Physiology of bone
formation, remodeling, and metabolism. In: Radionuclide and Hybrid
Bone Imaging. Fogelman I, Gnanasegaran G and van der Wall H (eds).
Springer, Berlin, Heidelberg, pp29-57, 2012.
|
3
|
Strålberg F, Kassem A, Kasprzykowski F,
Abrahamson M, Grubb A, Lindholm C and Lerner UH: Inhibition of
lipopolysaccharide-induced osteoclast formation and bone resorption
in vitro and in vivo by cysteine proteinase inhibitors. J Leukoc
Biol. 101:1233–1243. 2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Demontiero O, Vidal C and Duque G: Aging
and bone loss: New insights for the clinician. Ther Adv
Musculoskelet Dis. 4:61–76. 2012.PubMed/NCBI View Article : Google Scholar
|
5
|
Jiang N and Xia W: Assessment of bone
quality in patients with diabetes mellitus. Osteoporos Int.
29:1721–1736. 2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Lin X, Xiong D, Peng YQ, Sheng ZF, Wu XY,
Wu XP, Wu F, Yuan LQ and Liao EY: Epidemiology and management of
osteoporosis in the People's Republic of China: Current
perspectives. Clin Interv Aging. 10:1017–1033. 2015.PubMed/NCBI View Article : Google Scholar
|
7
|
Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang
Q, Huang J, Wen Q, Hu R, Wang L, et al: The prevalence of
osteoporosis in China, a nationwide, multicenter DXA survey. J Bone
Miner Res. 34:1789–1797. 2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Cui Z, Meng X, Feng H, Zhuang S, Liu Z,
Zhu T, Ye K, Xing Y, Sun C, Zhou F, et al: Estimation and
projection about the standardized prevalence of osteoporosis in
mainland China. Arch Osteoporos. 15(2)2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Skjødt MK, Frost M and Abrahamsen B: Side
effects of drugs for osteoporosis and metastatic bone disease. Br J
Clin Pharmacol. 85:1063–1071. 2019.PubMed/NCBI View Article : Google Scholar
|
10
|
Li K, Chen S, Cai P, Chen K, Li L, Yang X,
Yi J, Luo X, Du Y and Zheng H: miRNA-483-5p is involved in the
pathogenesis of osteoporosis by promoting osteoclast
differentiation. Mol Cell Probes. 49(101479)2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Li JY, Wei X, Sun Q, Zhao XQ, Zheng CY,
Bai CX, Du J, Zhang Z, Zhu LG and Jia YS: MicroRNA-449b-5p promotes
the progression of osteoporosis by inhibiting osteogenic
differentiation of BMSCs via targeting Satb2. Eur Rev Med Pharmacol
Sci. 23:6394–6403. 2019.PubMed/NCBI View Article : Google Scholar
|
12
|
Kida K, Nakajima M, Mohri T, Oda Y, Takagi
S, Fukami T and Yokoi T: PPARα is regulated by miR-21 and miR-27b
in human liver. Pharm Res. 28:2467–2476. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen D, Si W, Shen J, Du C, Lou W, Bao C,
Zheng H, Pan J, Zhong G, Xu L, et al: miR-27b-3p inhibits
proliferation and potentially reverses multi-chemoresistance by
targeting CBLB/GRB2 in breast cancer cells. Cell Death Dis.
9(188)2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Henriksen TI, Davidsen PK, Pedersen M,
Schultz HS, Hansen NS, Larsen TJ, Vaag A, Pedersen BK, Nielsen S
and Scheele C: Dysregulation of a novel miR-23b/27b-p53 axis
impairs muscle stem cell differentiation of humans with type 2
diabetes. Mol Metab. 6:770–779. 2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Wu X, Yan T, Wang Z, Wu X, Cao G and Zhang
C: lncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and
inhibits apoptosis by regulating miR-27b. Biomed Pharmacother.
96:299–304. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
Han Z, Zhan R, Chen S, Deng J, Shi J and
Wang W: miR-181b/Oncostatin m axis inhibits prostate cancer bone
metastasis via modulating osteoclast differentiation. J Cell
Biochem. 121:1664–1674. 2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Takigawa S, Chen A, Wan Q, Na S, Sudo A,
Yokota H and Hamamura K: Role of miR-222-3p in c-Src-Mediated
Regulation of Osteoclastogenesis. Int J Mol Sci.
17(240)2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Seenprachawong K, Tawornsawutruk T,
Nantasenamat C, Nuchnoi P, Hongeng S and Supokawej A: miR-130a and
miR-27b enhance osteogenesis in human bone marrow mesenchymal stem
cells via specific down-regulation of peroxisome
proliferator-activated receptor γ. Front Genet.
9(543)2018.PubMed/NCBI View Article : Google Scholar
|
19
|
Peng W, Zhu S, Li X, Weng J and Chen S:
miR-27b-3p suppressed osteogenic differentiation of maxillary sinus
membrane stem cells by targeting Sp7. Implant Dent. 26:492–499.
2017.PubMed/NCBI View Article : Google Scholar
|
20
|
Guo M, Li C, Lei Y, Xu S, Zhao D and Lu
X-Y: Role of the adipose PPARγ-adiponectin axis in susceptibility
to stress and depression/anxiety-related behaviors. Mol Psychiatry.
22:1056–1068. 2017.PubMed/NCBI View Article : Google Scholar
|
21
|
Calvier L, Chouvarine P, Legchenko E,
Hoffmann N, Geldner J, Borchert P, Jonigk D, Mozes MM and Hansmann
G: PPARγ links BMP2 and TGFβ1 pathways in vascular smooth muscle
cells, regulating cell proliferation and glucose metabolism. Cell
Metab. 25:1118–1134.e1117. 2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Ye G, Gao H, Wang Z, Lin Y, Liao X, Zhang
H, Chi Y, Zhu H and Dong S: PPARα and PPARγ activation attenuates
total free fatty acid and triglyceride accumulation in macrophages
via the inhibition of Fatp1 expression. Cell Death Dis.
10(39)2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Wan Y, Chong L-W and Evans RM: PPAR-γ
regulates osteoclastogenesis in mice. Nat Med. 13:1496–1503.
2007.PubMed/NCBI View
Article : Google Scholar
|
24
|
Zhuang H, Zhang X, Zhu C, Tang X, Yu F,
Shang GW and Cai X: Molecular mechanisms of PPAR-γ governing MSC
osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther.
11:255–264. 2016.PubMed/NCBI View Article : Google Scholar
|
25
|
Xu J, Lv S, Hou Y, Xu K, Sun D, Zheng Y,
Zhang Z, Li X, Li Y and Chi G: miR-27b promotes type II collagen
expression by targetting peroxisome proliferator-activated
receptor-γ2 during rat articular chondrocyte differentiation.
Biosci Rep. 38(BSR20171109)2018.PubMed/NCBI View Article : Google Scholar
|
26
|
Xu WN, Zheng HL, Yang RZ, Jiang LS and
Jiang SD: HIF-1α Regulates Glucocorticoid-Induced Osteoporosis
Through PDK1/AKT/mTOR Signaling Pathway. Front Endocrinol
(Lausanne). 10(922)2020.PubMed/NCBI View Article : Google Scholar
|
27
|
Li P, Mao WW, Zhang S, Zhang L, Chen ZR
and Lu ZD: Sodium hydrosulfide alleviates dexamethasone-induced
cell senescence and dysfunction through targeting the miR-22/sirt1
pathway in osteoblastic MC3T3-E1 cells. Exp Ther Med.
21(238)2021.PubMed/NCBI View Article : Google Scholar
|
28
|
Yang L, Liu S, Mu S, Guo R, Zhou L and Fu
Q: Paeoniflorin Attenuates Dexamethasone-Induced Apoptosis of
Osteoblast Cells and Promotes Bone Formation via Regulating
AKT/mTOR/Autophagy Signaling Pathway. Evid Based Complement
Alternat Med. 2021(6623464)2021.PubMed/NCBI View Article : Google Scholar
|
29
|
Zhu C, Zheng XF, Yang YH, Li B, Wang YR,
Jiang SD and Jiang LS: LGR4 acts as a key receptor for R-spondin 2
to promote osteogenesis through Wnt signaling pathway. Cell Signal.
28:989–1000. 2016.PubMed/NCBI View Article : Google Scholar
|
30
|
Gulyaeva LF and Kushlinskiy NE: Regulatory
mechanisms of microRNA expression. J Transl Med.
14(143)2016.PubMed/NCBI View Article : Google Scholar
|
31
|
Ge DW, Wang WW, Chen HT, Yang L and Cao
XJ: Functions of microRNAs in osteoporosis. Eur Rev Med Pharmacol
Sci. 21:4784–4789. 2017.PubMed/NCBI
|
32
|
Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y
and Liao Y: miRNA-19a-3p alleviates the progression of osteoporosis
by targeting HDAC4 to promote the osteogenic differentiation of
hMSCs. Biochem Biophys Res Commun. 516:666–672. 2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Li QQ, Wei Q, Zhai XC, Qin L, Li HB, Meng
R and Chen SC: miRNA-7b-5p attenuates the progression of
osteoporosis by inhibiting adipose differentiation of hMSCs via
regulating IRS2. Eur Rev Med Pharmacol Sci. 23:9207–9214.
2019.PubMed/NCBI View Article : Google Scholar
|
34
|
Lee JJ, Drakaki A, Iliopoulos D and Struhl
K: miR-27b targets PPARγ to inhibit growth, tumor progression and
the inflammatory response in neuroblastoma cells. Oncogene.
31:3818–3825. 2012.PubMed/NCBI View Article : Google Scholar
|
35
|
Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan
Y, Guan W and Zou C: miR-27b-3p suppresses cell proliferation
through targeting receptor tyrosine kinase like orphan receptor 1
in gastric cancer. J Exp Clin Cancer Res. 34(139)2015.PubMed/NCBI View Article : Google Scholar
|
36
|
Wang J, Song Y, Zhang Y, Xiao H, Sun Q,
Hou N, Guo S, Wang Y, Fan K, Zhan D, et al: Cardiomyocyte
overexpression of miR-27b induces cardiac hypertrophy and
dysfunction in mice. Cell Res. 22:516–527. 2012.PubMed/NCBI View Article : Google Scholar
|
37
|
Hou N, Wang J, Li Z, Cao Y, Fan K and Yang
X: Cardiomycyte overexpression of miR-27b resulted in cardiac
fibrosis and mitochondria injury in mice. Yi Chuan. 34:326–334.
2012.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
38
|
Li YF, Li SH, Liu Y and Luo YT: Long
noncoding RNA CIR promotes chondrocyte extracellular matrix
degradation in osteoarthritis by acting as a sponge for Mir-27b.
Cell Physiol Biochem. 43:602–610. 2017.PubMed/NCBI View Article : Google Scholar
|
39
|
Xu D, Gao Y, Hu N, Wu L and Chen Q:
miR-365 Ameliorates Dexamethasone-Induced Suppression of
Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4. Int J Mol Sci.
18(977)2017.PubMed/NCBI View Article : Google Scholar
|
40
|
Tang J, Yu H, Wang Y, Duan G, Wang B, Li W
and Zhu Z: MicroRNA-199a counteracts glucocorticoid inhibition of
bone marrow mesenchymal stem cell osteogenic differentiation
through regulation of Klotho expression in vitro. Cell Biol Int.
44:2532–2540. 2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Shen GY, Ren H, Shang Q, Zhao WH, Zhang
ZD, Yu X, Huang JJ, Tang JJ, Yang ZD, Liang D, et al: Let-7f-5p
regulates TGFBR1 in glucocorticoid-inhibited osteoblast
differentiation and ameliorates glucocorticoid-induced bone loss.
Int J Biol Sci. 15:2182–2197. 2019.PubMed/NCBI View Article : Google Scholar
|
42
|
Li H, Li T, Fan J, Li T, Fan L, Wang S,
Weng X, Han Q and Zhao RC: miR-216a rescues dexamethasone
suppression of osteogenesis, promotes osteoblast differentiation
and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT
pathway. Cell Death Differ. 22:1935–1945. 2015.PubMed/NCBI View Article : Google Scholar
|
43
|
Corrales P, Izquierdo-Lahuerta A and
Medina-Gómez G: Maintenance of kidney metabolic homeostasis by PPAR
gamma. Int J Mol Sci. 19(2063)2018.PubMed/NCBI View Article : Google Scholar
|
44
|
Karbiener M, Fischer C, Nowitsch S,
Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ and Scheideler M:
MicroRNA miR-27b impairs human adipocyte differentiation and
targets PPARgamma. Biochem Biophys Res Commun. 390:247–251.
2009.PubMed/NCBI View Article : Google Scholar
|
45
|
Shockley KR, Lazarenko OP, Czernik PJ,
Rosen CJ, Churchill GA and Lecka-Czernik B: PPARgamma2 nuclear
receptor controls multiple regulatory pathways of osteoblast
differentiation from marrow mesenchymal stem cells. J Cell Biochem.
106:232–246. 2009.PubMed/NCBI View Article : Google Scholar
|
46
|
Guo L, Chen K, Yuan J, Huang P, Xu X, Li
C, Qian N, Qi J, Shao Z, Deng L, et al: Estrogen inhibits
osteoclasts formation and bone resorption via microRNA-27a
targeting PPARγ and APC. J Cell Physiol. 234:581–594.
2018.PubMed/NCBI View Article : Google Scholar
|
47
|
Patel JJ, Butters OR and Arnett TR: PPAR
agonists stimulate adipogenesis at the expense of osteoblast
differentiation while inhibiting osteoclast formation and activity.
Cell Biochem Funct. 32:368–377. 2014.PubMed/NCBI View Article : Google Scholar
|
48
|
Wang H and Shen Y: MicroRNA 20a negatively
regulates the growth and osteoclastogenesis of THP 1 cells by
downregulating PPARγ. Mol Med Rep. 20:4271–4276. 2019.PubMed/NCBI View Article : Google Scholar
|
49
|
Wang Y, Pan Z and Chen F: Inhibition of
PPARγ by bisphenol A diglycidyl ether ameliorates
dexamethasone-induced osteoporosis in a mouse model. J Int Med Res.
47:6268–6277. 2019.PubMed/NCBI View Article : Google Scholar
|